Published: May 28, 2020

Beta Alpha/UCLA Doc Recovers from COVID-19 and Returns to the Frontline

Dr. Bruce Gelb (Beta Alpha/UCLA 1996), a transplant surgeon in New York City, contracted COVID-19 in March 2020. Since recovering, he has been on the frontline, attending to the most critically ill patients in New York City.

Dr. Gelb shared his experience with the disease in an article for TIME Magazine. Click here to access the original article.

Dr. Bruce Gelb, MD FACS is a clinical transplant surgeon who performs liver, kidney, pancreas, and living donor transplant surgery. He is a key member of the NYU Langone Health vascularized composite allograft (VCA) team and develops and manages immunosuppression regimens for face and hand transplant recipients. His patients have had the longest rejection free periods reported for face transplant recipients.

Dr. Gelb has served as the Chair of the Quality Improvement Committee of NYU Langone Health System. He has also served on the United Network for Organ Sharing (UNOS) Ethics Committee, the American Society of Transplant Surgeons (ASTS) Legislative Committee, and is a current member of the ASTS and UNOS Vascularized Composite Allograft (VCA) Committees.

He is concerned with a variety of issues in bioethics, with particular interest in the ethics of transplantation and organ donation. He is the immediate past-President and currently serves on the Board of Directors of the Global Bioethics Initiative, an NGO member of the United Nations Academic Impact with special consultative status with the UN Economic and Social Council (ECOSOC).

Founded in 1856, Theta Chi Fraternity is a men’s collegiate fraternity with more than 191,000 initiated members and has established 241 chapters. Leadership development, personal development, and service to alma mater are fundamental to Theta Chi Fraternity’s mission.